Therefore, tracking ongoing research, competitor moves, and new opportunities is important for companies to become early movers and gain a competitive advantage
Furthermore, such interactions extend beyond CYP3A4
Supplementary Data 4 (download XLSX Source data for Supplementary Fig
Diabetes Ther Res Treat Educ Diabetes Relat Disord 9(5):19952014
Given the heterogeneity among GLP-1RAs in terms of pharmacokinetic profiles, therapeutic efficacy, adverse event rates, and dosing regimens, each agent should be assessed individually
What's more, doctors say most people are taking GLP-1 medications to manage weight, heart failure or sleep apnea, not to prevent cancer